Dehui Zhang

Title: Dehui Zhang: Innovator in Cancer Therapeutics

Introduction

Dehui Zhang is a prominent inventor based in Chapel Hill, NC, known for his significant contributions to cancer treatment innovations. With a focus on therapeutic combinations, Zhang has developed groundbreaking methods that enhance the efficacy of cancer therapies.

Latest Patents

Zhang holds 2 patents, including his latest inventions: Pan-TAM inhibitors and Mer/Axl dual inhibitors. These inventions aim to improve therapeutic combinations for treating selected cancers using specific pyrimidine compounds that exhibit pan-TAM or Mer/Axl dual receptor tyrosine kinase inhibitory activity. His work emphasizes the combination of these compounds with immune checkpoint inhibitors, such as CTLA4 inhibitors, PD1 inhibitors, or PDL-1 inhibitors, to provide enhanced treatment options for patients.

Career Highlights

Zhang is affiliated with the University of North Carolina at Chapel Hill, where he conducts research and develops innovative cancer therapies. His work has been instrumental in advancing the understanding of how specific compounds can be utilized in cancer treatment.

Collaborations

Zhang collaborates with notable colleagues, including Xiaodong Wang and Dmitri Kireev, to further his research and development efforts in the field of cancer therapeutics.

Conclusion

Dehui Zhang's contributions to cancer treatment through his innovative patents and research at the University of North Carolina at Chapel Hill highlight his commitment to improving patient outcomes. His work continues to pave the way for advancements in cancer therapy.